APA (7th ed.) Citation

Qiuji Wu, Qiu Li, Jun Zhang, Zhumei Luo, Jin Zhou, Jing Chen, & Yong Luo. (2021). Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte-Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Qiuji Wu, Qiu Li, Jun Zhang, Zhumei Luo, Jin Zhou, Jing Chen, and Yong Luo. Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte-Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Qiuji Wu, et al. Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte-Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study. Frontiers Media S.A., 2021.